TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16320858

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (CEE) daily and twice daily 20 mg transdermal progesterone cream (PC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: 0.625 mg conjugated equine estrogen (CEE) daily and 2.5 mg medroxyprogesterone acetate (MPA)
Number of subjects: 26
Study: 12193430

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at 6.0 IU/m2/day for at least two years
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 35
Study: 9825314

Group type: EXPERIMENTAL
Intervention: DDD pacing with rate drop response function (11 patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: DDI pacing with rate hysteresis (8 patients)
Number of subjects: 20
Study: 8633181

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2698571

Group type: EXPERIMENTAL
Intervention: Gallopamil retard at a dosage of 75 mg b.i.d.
Number of subjects: 0
Study: 62991

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278

Group type: COMPARATOR
Intervention: No tablets at all
Number of subjects: 278
Study: 31302489

Group type: EXPERIMENTAL
Intervention: 8 week static calf stretching intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual activity (control)
Number of subjects: 68
Study: 26935479

Group type: EXPERIMENTAL
Intervention: pink-veneered zirconia abutments (test group; n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: non-veneered white zirconia abutments (control group; n = 10)
Number of subjects: 20
Study: 26652009

Group type: EXPERIMENTAL
Intervention: Preoperative rectus sheath block (RSB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Postoperative rectus sheath block (RSB)
Number of subjects: 64
Study: 23787940

Group type: EXPERIMENTAL
Intervention: Dance Dance Revolution (supervised)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Handheld game (without supervision)
Number of subjects: 18
Study: 21559803

Group type: EXPERIMENTAL
Intervention: Alcohol (n=37; average peak BAC=0.087 g/100 ml)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (n=42)
Number of subjects: 79
Study: 18718886

Group type: EXPERIMENTAL
Intervention: Facilitator enhanced multifaceted intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 30
Study: 16374471

Group type: EXPERIMENTAL
Intervention: Topical methyl 5-aminolevulinate (MAL) cream at concentrations of 16-160 mg/g applied for 3 hours and 18 hours.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical methyl 5-aminolevulinate (MAL) cream at concentrations of 16-160 mg/g applied for 18 hours.
Number of subjects: 50
Study: 14984131

Group type: EXPERIMENTAL
Intervention: Foster placement as an alternative to institutionalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Institutionalization
Number of subjects: 0
Study: 10886577

Group type: EXPERIMENTAL
Intervention: Mizoribine
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Mizoribine (in patients 10 years old or younger)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo (in patients 10 years old or younger)
Number of subjects: 197
Study: 8721273

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole a day orally for 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8134169

Group type: EXPERIMENTAL
Intervention: Formula containing 0.13 mumol/L (10 micrograms/L) Se
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Increased consumption of solid foods
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Formula containing 0.26‐0.33 mumol/L (20‐25 micrograms/L) Se (suggested)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Males vs. Females
Number of subjects: 82
Study: 2891518

Group type: EXPERIMENTAL
Intervention: LH-RH nasal spray
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: LH-RH nasal spray (including subsequent open study and second course)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Follow-up period
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Retrospective evaluation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Hormonal evaluation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Pretreatment testicular position
Number of subjects: 252
Study: 29903761

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 151
Study: 25580428

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Hormonal therapy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 450

Group type: COMPARATOR
Intervention: All treatment options
Number of subjects: 450
Study: 22213770

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 17
Study: 20581420

Group type: EXPERIMENTAL
Intervention: Multicomponent school-based intervention
Number of subjects: 4603

Group type: COMPARATOR
Intervention: Assessment only (control)
Number of subjects: 4603
Study: 18616866

Group type: EXPERIMENTAL
Intervention: Phosphatidylserine (PS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16163628

Group type: EXPERIMENTAL
Intervention: Ceftazidime alone
Number of subjects: 449

Group type: COMPARATOR
Intervention: Ceftazidime with TMP-SMX
Number of subjects: 449
Study: 12190760

Group type: EXPERIMENTAL
Intervention: Single intravenous cannula used for both intra‐operative and postoperative purposes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Two cannulae, one used intra‐operatively and the other postoperatively
Number of subjects: 60
Study: 10589379

Group type: EXPERIMENTAL
Intervention: Nutritional support
Number of subjects: 0
Study: 7850328

Group type: EXPERIMENTAL
Intervention: Neoadjuvant or concurrent single-agent cisplatin followed by local definitive treatment
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin and doxorubicin)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Age < 60 years
Number of subjects: 804
Study: 2182103

Group type: EXPERIMENTAL
Intervention: Spectacles treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spectacles treatment (subgroup of consistent wearers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spectacles treatment (subgroup of inconsistent wearers)
Number of subjects: 0
Study: 377462

Group type: EXPERIMENTAL
Intervention: Excision and skin grafting
Number of subjects: 222

Group type: COMPARATOR
Intervention: Conservative management (scarlet red gauze dressing)
Number of subjects: 222
Study: 31097519

Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator (t‐PA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: recombinant human DNase
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: t‐PA-DNase
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo vs t‐PA-DNase
Number of subjects: 0
Study: 28255812

Group type: EXPERIMENTAL
Intervention: Low-intensity training group (LIPRT, n=13, 15% maximal inspiratory workload, 0.5 kg peripheral muscle workload)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moderate-intensity training group (MIPRT, n=13, 30% maximal inspiratory workload, 50% of one maximum repetition of peripheral muscle workload)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-exercise control group (n=9)
Number of subjects: 35
Study: 26047602

Group type: EXPERIMENTAL
Intervention: Standardized Patients (SP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: High-Fidelity Simulators (HFS)
Number of subjects: 57
Study: 22305437

Group type: EXPERIMENTAL
Intervention: 3D-SPACE
Number of subjects: 25

Group type: COMPARATOR
Intervention: PC-MRI
Number of subjects: 25
Study: 21310088

Group type: EXPERIMENTAL
Intervention: PURIAM110 dietary supplement
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 19797148

Group type: EXPERIMENTAL
Intervention: Epicardial lead placement
Number of subjects: 23

Group type: COMPARATOR
Intervention: Transvenous CRT
Number of subjects: 23
Study: 16915077

Group type: EXPERIMENTAL
Intervention: Intrarectal manipulation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-power external physiotherapy
Number of subjects: 102
Study: 14994556

Group type: EXPERIMENTAL
Intervention: Heart Attack Survival Kit delivered by firefighters
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 323
Study: 11506108

Group type: EXPERIMENTAL
Intervention: Hydration with 15 ml/kg crystalloid immediately before spinal anesthesia
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hydration with 15 ml/kg crystalloid starting with the spinal anesthetic injection
Number of subjects: 48

Group type: COMPARATOR
Intervention: No prehydration (control)
Number of subjects: 48
Study: 9143171

Group type: EXPERIMENTAL
Intervention: Intra-operative sentinel lymph node mapping and biopsy using radiocolloid, handheld gamma probe, and vital blue dye.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-operative sentinel lymph node mapping and biopsy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identification and removal of regional lymph nodes containing metastatic melanoma.
Number of subjects: 0
Study: 8195987

Group type: EXPERIMENTAL
Intervention: Affiliation with someone awaiting the same threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonverbal affiliation (facial glances)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Affiliation effects on anxiety
Number of subjects: 0
Study: 3066854

Group type: EXPERIMENTAL
Intervention: Misonidazole (total dose of about 11 g/m2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: COMPARATOR
Intervention: Misonidazole and Placebo (combined)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 70
Study: 29996798

Group type: EXPERIMENTAL
Intervention: 5% duty cycle (DC) subthreshold laser treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 15% duty cycle (DC) subthreshold laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous wave (CW) laser treatment
Number of subjects: 20
Study: 28495809

Group type: COMPARATOR
Intervention: Intravenous potassium replacement (IVPR)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Enteral potassium replacement (EPR)
Number of subjects: 41
Study: 25608273

Group type: EXPERIMENTAL
Intervention: The Pink Women's Wellness Program (lifestyle intervention including clinical consultations and tailored health education)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: The Pink Women's Wellness Program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 55
Study: 23531329

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid supplementation
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid supplementation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cesarean delivery
Number of subjects: 126
Study: 20958277

Group type: EXPERIMENTAL
Intervention: ropivacaine 0.25%
Number of subjects: 48

Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 48
Study: 17965109

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (4 mg/0.1 ml)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bevacizumab (1.5 mg/0.06 ml)
Number of subjects: 28
Study: 17030525

Group type: EXPERIMENTAL
Intervention: HIV behavioural intervention
Number of subjects: 1277
Study: 12942187

Group type: EXPERIMENTAL
Intervention: Finasteride for male pattern hair loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser-assisted hair removal systems for hypertrichosis and hirsutism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 17α-estradiol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical minoxidil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical immunotherapy for alopecia areata
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modern broad spectrum antimycotic agents for infectious scarring alopecias
Number of subjects: 0
Study: 11012956

Group type: EXPERIMENTAL
Intervention: ketorolac 0.5% ophthalmic solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 9001827

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray 200 micrograms once daily (n = 77)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Oral fluticasone propionate 5 mg once daily (n = 73)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Oral fluticasone propionate 10 mg once daily (n = 77)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo (n = 77)
Number of subjects: 304
Study: 1282613

Group type: EXPERIMENTAL
Intervention: Nisoldipine (50 micrograms intracoronary)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diltiazem (500 micrograms intracoronary)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SIN-1 (500 micrograms intracoronary)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6374932

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 0
Study: 31577081

Group type: EXPERIMENTAL
Intervention: i.v. combination of ampicillin + sulbactam with daily cleaning of tonsillar lesions
Number of subjects: 2

Group type: COMPARATOR
Intervention: i.v. combination of ampicillin + sulbactam
Number of subjects: 2
Study: 29030111

Group type: EXPERIMENTAL
Intervention: LFMS treatment (20 min/day for 4 days)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham treatment (20 min/day for 4 days)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham treatment (20 min/day for 2 days followed by LFMS treatment 20 min/day for 2 days)
Number of subjects: 84
Study: 27639997

Group type: EXPERIMENTAL
Intervention: Group C (fragile oocytes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group A (normal oocytes, no fragile oocytes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (normal oocytes, at least one fragile oocyte)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (including Group C)
Number of subjects: 0
Study: 25298321

Group type: EXPERIMENTAL
Intervention: 20 mg yohimbine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 23094034

Group type: EXPERIMENTAL
Intervention: Booklet combined with a short ICF
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Booklet combined with a simplified ICF
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard ICF
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Simplified ICF
Number of subjects: 282
Study: 21175018

Group type: EXPERIMENTAL
Intervention: Indirectly bonded brackets with methyl methacrylate monomer (MMM) conditioned custom bases
Number of subjects: 36

Group type: COMPARATOR
Intervention: Indirectly bonded brackets without conditioning (Control group)
Number of subjects: 36
Study: 17981189

Group type: EXPERIMENTAL
Intervention: Mesh repair
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-mesh repair
Number of subjects: 300
Study: 14693772

Group type: EXPERIMENTAL
Intervention: lyophilisate (68 microg fluorescein SE 0.17%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: preservative free eye drop (40 microg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: lyophilisate
Number of subjects: 20
Study: 11990727

Group type: EXPERIMENTAL
Intervention: Ultrasonograph muscle thickness measurements
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multiple regression equation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Simple regression equation
Number of subjects: 46
Study: 9830243

Group type: EXPERIMENTAL
Intervention: SocAnh group (n = 34)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (n = 139)
Number of subjects: 173
Study: 7862876

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneously)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2510191

Group type: EXPERIMENTAL
Intervention: L-Carnitina (1 g endovenous, per orally administered vials, tablets)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 31897572

Group type: EXPERIMENTAL
Intervention: Treatment (alcohol, hypnotics, sleep deprivation)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Baseline SDLP
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Treatment-induced changes in SDLP
Number of subjects: 315
Study: 29984800

Group type: EXPERIMENTAL
Intervention: Loading of the tympanic membrane with 340 mg (25 λ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Loading of the tympanic membrane with 544 mg (40 λ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no loading)
Number of subjects: 60
Study: 27657799

Group type: EXPERIMENTAL
Intervention: Cardiac web-based eLearning platform in addition to conventional cardiac care
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Conventional cardiac care alone
Number of subjects: 1000
Study: 25200170

Group type: EXPERIMENTAL
Intervention: Bariatric Rehabilitation Service (BRS) - three 50-min one-to-one sessions with a health psychologist
Number of subjects: 162

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 162
Study: 23623861

Group type: EXPERIMENTAL
Intervention: Humanoid robot interaction during vaccination
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard administration procedures without robot
Number of subjects: 57
Study: 20850390

Group type: COMPARATOR
Intervention: Intradiscal injection of normal saline
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intradiscal injection of diprospan
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intradiscal injection of diprospan+songmeile
Number of subjects: 120
Study: 19225122

Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D supplementation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D supplementation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 400 IU/d vitamin D supplementation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no supplements or own supplements)
Number of subjects: 55
Study: 16472562

Group type: EXPERIMENTAL
Intervention: Continuous oral contraceptive (OC) use
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional oral contraceptive (OC) use
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Post-OC discontinuation
Number of subjects: 36
Study: 14517547

Group type: EXPERIMENTAL
Intervention: Mail intervention
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Phone intervention
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1801
Study: 10920614

Group type: EXPERIMENTAL
Intervention: Mycobacterium w antileprosy vaccine
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 157
Study: 8847984

Group type: EXPERIMENTAL
Intervention: Magnetic fields (ELF‐MF) therapy, 20 procedures using Aplhatron 4100 device
Number of subjects: 96

Group type: COMPARATOR
Intervention: Simulated treatment (control group of 29 sawyers)
Number of subjects: 96
Study: 1575065

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 8 mg twice daily
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 12 mg twice daily
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg twice daily
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Astemizole, 10 mg/d
Number of subjects: 1
Study: 3886709

Group type: EXPERIMENTAL
Intervention: Digoxin alone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Digoxin with ethmozine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ethmozine alone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ethmozine with digoxin
Number of subjects: 9
Study: 31392207

Group type: EXPERIMENTAL
Intervention: Two-stage teaching technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Four-stage teaching technique
Number of subjects: 0
Study: 29320655

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer
Number of subjects: 782

Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 782
Study: 26885791

Group type: EXPERIMENTAL
Intervention: Herbal-based cosmeceutical regimen (novel herbal blend)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Common antiaging topical treatments (prescription tretinoin, idebenone, kinetin, polyhydroxy, lactic and glycolic acids)
Number of subjects: 110
Study: 24057990

Group type: EXPERIMENTAL
Intervention: Pamphlet
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pamphlet/benefit statement
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pamphlet and Pamphlet/benefit statement
Number of subjects: 135
Study: 22933237

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 20040167

Group type: EXPERIMENTAL
Intervention: Practice nurse group
Number of subjects: 701

Group type: COMPARATOR
Intervention: GP group
Number of subjects: 701
Study: 19138428

Group type: EXPERIMENTAL
Intervention: Regression-based methods for adjusting publication bias
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trim & Fill algorithm
Number of subjects: 0
Study: 16261600

Group type: EXPERIMENTAL
Intervention: Chocolate deprivation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Vanilla deprivation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Nondeprivation
Number of subjects: 103
Study: 12153623

Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 240

Group type: COMPARATOR
Intervention: Colostomy
Number of subjects: 240
Study: 10623364

Group type: EXPERIMENTAL
Intervention: H2‐receptor antagonist maintenance therapy with ranitidine (150 mg daily)
Number of subjects: 119

Group type: COMPARATOR
Intervention: H. pylori eradication therapy using an omeprazole/amoxicillin/metronidazole regimen
Number of subjects: 119
Study: 7582388

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg on day 1 and 250 mg on days 2-5)
Number of subjects: 10